{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:15:49Z","timestamp":1792041349827,"version":"4.4.0"},"reference-count":36,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institute for Cancer Research, London"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1210\/jc.2017-02529","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T14:03:08Z","timestamp":1521813788000},"page":"4275-4282","source":"Crossref","is-referenced-by-count":62,"title":["p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer"],"prefix":"10.1210","volume":"103","author":[{"given":"Chey","family":"Loveday","sequence":"first","affiliation":[{"name":"Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Josephs","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, St George\u2019s University Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chubb","sequence":"additional","affiliation":[{"name":"Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Gunning","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Izatt","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Tischkowitz","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Ellard","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Turnbull","sequence":"additional","affiliation":[{"name":"Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom"},{"name":"Department of Clinical Genetics, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom"},{"name":"William Harvey Research Institute, Queen Mary University, London, United Kingdom"},{"name":"National Cancer Registration and Analysis Service, Public Health England, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,3,23]]},"reference":[{"issue":"3","key":"key\n\t\t\t\t20181019083448388_B1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jcp.18.3.288","article-title":"A review of 17 cases of carcinoma of the thyroid and phaeochromocytoma","volume":"18","author":"Williams","year":"1965","journal-title":"J Clin Pathol"},{"issue":"1","key":"key\n\t\t\t\t20181019083448388_B2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/path.1700910109","article-title":"Multiple mucosal neuromata with endocrine tumours: a syndrome allied to von Recklinghausen\u2019s disease","volume":"91","author":"Williams","year":"1966","journal-title":"J Pathol Bacteriol"},{"issue":"5","key":"key\n\t\t\t\t20181019083448388_B3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005792-196809000-00001","article-title":"Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing\u2019s disease: multiple endocrine neoplasia, type 2","volume":"47","author":"Steiner","year":"1968","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"key\n\t\t\t\t20181019083448388_B4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","article-title":"Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC","volume":"2","author":"Donis-Keller","year":"1993","journal-title":"Hum Mol Genet"},{"issue":"6428","key":"key\n\t\t\t\t20181019083448388_B5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"issue":"6","key":"key\n\t\t\t\t20181019083448388_B6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"},{"issue":"6","key":"key\n\t\t\t\t20181019083448388_B7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"7616","key":"key\n\t\t\t\t20181019083448388_B8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"issue":"34","key":"key\n\t\t\t\t20181019083448388_B9","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1200\/JCO.2016.67.0554","article-title":"Population frequency of germline BRCA1\/2 mutations","volume":"34","author":"Maxwell","year":"2016","journal-title":"J Clin Oncol"},{"issue":"322","key":"key\n\t\t\t\t20181019083448388_B10","doi-asserted-by":"crossref","first-page":"322ra9","DOI":"10.1126\/scitranslmed.aad5169","article-title":"Quantifying prion disease penetrance using large population control cohorts","volume":"8","author":"Minikel","year":"2016","journal-title":"Sci Transl Med"},{"issue":"8","key":"key\n\t\t\t\t20181019083448388_B11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/gim.2015.180","article-title":"Exploring the landscape of pathogenic genetic variation in the ExAC population database: insights of relevance to variant classification","volume":"18","author":"Song","year":"2016","journal-title":"Genet Med"},{"key":"key\n\t\t\t\t20181019083448388_B12","unstructured":"Marquard J, Eng C. Multiple endocrine neoplasia type 2. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJG, Stephens K, Amemiya A, eds. GeneReviews\u00ae. Seattle, WA: University of Washington. Available at: www.ncbi.nlm.nih.gov\/books\/NBK1257\/. Accessed September 2017."},{"key":"key\n\t\t\t\t20181019083448388_B13","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"key\n\t\t\t\t20181019083448388_B14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/gim.2017.26","article-title":"Using high-resolution variant frequencies to empower clinical genome interpretation","volume":"19","author":"Whiffin","year":"2017","journal-title":"Genet Med"},{"key":"key\n\t\t\t\t20181019083448388_B15","unstructured":"Orphanet. Multiple endocrine neoplasia type 2. Available at: www.orpha.net\/consor\/cgi-bin\/OC_Exp.php?Lng=GB&Expert=653. Accessed September 2017."},{"key":"key\n\t\t\t\t20181019083448388_B16","unstructured":"Cancer Research UK. Thyroid cancer incidence statistics. Available at: www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/thyroid-cancer\/incidence. Accessed September 2017."},{"key":"key\n\t\t\t\t20181019083448388_B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12515","article-title":"Guidelines for the management of thyroid cancer","volume":"81","author":"Perros","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"key\n\t\t\t\t20181019083448388_B18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ncpendmet0717","article-title":"New therapeutic approaches to treat medullary thyroid carcinoma","volume":"4","author":"Schlumberger","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t20181019083448388_B19","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/cen.12686","article-title":"Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer","volume":"82","author":"Romei","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"key\n\t\t\t\t20181019083448388_B20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-10-0333","article-title":"Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes","volume":"163","author":"Romei","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"key\n\t\t\t\t20181019083448388_B21","first-page":"1780","article-title":"Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype","volume":"81","author":"Frank-Raue","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"key\n\t\t\t\t20181019083448388_B22","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa012915","article-title":"Early malignant progression of hereditary medullary thyroid cancer","volume":"349","author":"Machens","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"key\n\t\t\t\t20181019083448388_B23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4274\/jcrpe.2219","article-title":"Distribution of RET mutations and evaluation of treatment approaches in hereditary medullary thyroid carcinoma in Turkey","volume":"8","author":"Aydo\u011fan","year":"2016","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"2","key":"key\n\t\t\t\t20181019083448388_B24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/thy.2016.0411","article-title":"Distribution of RET mutations in multiple endocrine neoplasia 2 in Denmark 1994\u20132014: a nationwide study","volume":"27","author":"Mathiesen","year":"2017","journal-title":"Thyroid"},{"issue":"1","key":"key\n\t\t\t\t20181019083448388_B25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1067\/msy.2000.107103","article-title":"Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation","volume":"128","author":"Feldman","year":"2000","journal-title":"Surgery"},{"issue":"6","key":"key\n\t\t\t\t20181019083448388_B26","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1067\/msy.2000.11\/6\/111080","article-title":"Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated","volume":"128","author":"Frohnauer","year":"2000","journal-title":"Surgery"},{"issue":"6","key":"key\n\t\t\t\t20181019083448388_B27","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2265.2005.02394.x","article-title":"Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations","volume":"63","author":"Learoyd","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"key\n\t\t\t\t20181019083448388_B28","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1089\/thy.2013.0620","article-title":"Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations","volume":"24","author":"Rich","year":"2014","journal-title":"Thyroid"},{"issue":"3","key":"key\n\t\t\t\t20181019083448388_B29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0022-3476(99)70129-0","article-title":"Familial medullary thyroid carcinoma: presymptomatic diagnosis and management in children","volume":"135","author":"Heptulla","year":"1999","journal-title":"J Pediatr"},{"issue":"12","key":"key\n\t\t\t\t20181019083448388_B30","doi-asserted-by":"crossref","first-page":"E363","DOI":"10.1002\/hed.23241","article-title":"Novel tandem germline RET proto-oncogene mutations in a patient with multiple endocrine neoplasia type 2B: report of a case and a literature review of tandem RET mutations with in silico analysis","volume":"35","author":"Nakao","year":"2013","journal-title":"Head Neck"},{"issue":"20","key":"key\n\t\t\t\t20181019083448388_B31","doi-asserted-by":"crossref","first-page":"10179","DOI":"10.1158\/0008-5472.CAN-06-0884","article-title":"RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B","volume":"66","author":"Cranston","year":"2006","journal-title":"Cancer Res"},{"issue":"5","key":"key\n\t\t\t\t20181019083448388_B32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1067\/msy.2002.123006","article-title":"V804M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriers","volume":"131","author":"Lecube","year":"2002","journal-title":"Surgery"},{"issue":"6","key":"key\n\t\t\t\t20181019083448388_B33","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1210\/jc.2004-1622","article-title":"Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma\/multiple endocrine neoplasia type 2A patients","volume":"90","author":"Lesueur","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"key\n\t\t\t\t20181019083448388_B34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/gim.2013.73","article-title":"ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing","volume":"15","author":"Green","year":"2013","journal-title":"Genet Med"},{"issue":"2","key":"key\n\t\t\t\t20181019083448388_B35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics","volume":"19","author":"Kalia","year":"2017","journal-title":"Genet Med"},{"issue":"2","key":"key\n\t\t\t\t20181019083448388_B36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/jc.2011-2046","article-title":"The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center","volume":"97","author":"Elisei","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/11\/4275\/26114805\/jc.2017-02529.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T06:00:48Z","timestamp":1570946448000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/11\/4275\/4951497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,23]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,3,23]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-02529","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,3,23]]}}}